Dr Reddy’s gets FDA nod to launch anti-asthma tablets in US – Economic Times

Dr Reddy's gets FDA nod to launch anti-asthma tablets in US
Economic Times
today said it has received approval from US health regulator to launch generic Zafirlukast tablets, used for treating asthma, in the American market.
Dr Reddys Laboratories announces the launch of Zafirlukast tabletsIndia Infoline.com

all 6 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.